Company intelligence / Profile preview

PneumaCare

Cambridge, England, United Kingdompneumacare.org ↗

Ownership: Private
Development stage: Other

Overview

PneumaCare develops and markets non-contact, non-invasive lung function imaging systems using structured light plethysmography. Their Thora‑3Di® system enables real-time regional respiratory monitoring by visualizing chest wall movement. The technology supports diagnosis and management of various pulmonary conditions in both adult and pediatric patients. It has been adopted by clinicians for pre/post-surgical assessments, drug/device trials, and routine care. Clinical feedback highlights its value in quantifying breathing patterns without exposing patients to aerosols or requiring physical contact.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Medical Imaging

Beyond the preview

Go deeper on PneumaCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PneumaCare.

Explore the full profile